Clinical Trials Browser

Phase 2 × DMMR Colorectal Cancer × toripalimab × Clear all

NCT04301557 2024-04-23

PD1 Antibody Toripalimab and Chemoradiotherapy for dMMR/MSI-H Locally Advanced Colorectal Cancer

Phase 2 Active not recruiting

GastrointestinalOther solid neoplasm

DMMR Colorectal Cancer